The European ADHD Guidelines Group (EAGG) recommends that patients who didn’t have an in-person assessment before stay-at-home orders began should delay starting a new medication if they have a history of shortness of breath or a family member who died due to cardiac disease. Patients should also undergo baseline monitoring — having their blood pressure and heart rate taken — before beginning medication.